These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20101009)

  • 1. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study.
    Ryan DH; Johnson WD; Myers VH; Prather TL; McGlone MM; Rood J; Brantley PJ; Bray GA; Gupta AK; Broussard AP; Barootes BG; Elkins BL; Gaudin DE; Savory RL; Brock RD; Datz G; Pothakamuri SR; McKnight GT; Stenlof K; Sjöström LV
    Arch Intern Med; 2010 Jan; 170(2):146-54. PubMed ID: 20101009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
    MacLaughlin HL; Cook SA; Kariyawasam D; Roseke M; van Niekerk M; Macdougall IC
    Am J Kidney Dis; 2010 Jan; 55(1):69-76. PubMed ID: 19926371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
    Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band.
    Zoss I; Piec G; Horber FF
    Obes Surg; 2002 Feb; 12(1):113-7. PubMed ID: 11868286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients.
    Kaya A; Aydin N; Topsever P; Filiz M; Oztürk A; Dağar A; Kilinç E; Ekmekcioglu C
    Biomed Pharmacother; 2004 Dec; 58(10):582-7. PubMed ID: 15589067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
    Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
    Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial].
    Toubro S; Hansen DL; Hilsted JC; Porsborg PA; Astrup AV;
    Ugeskr Laeger; 2001 May; 163(21):2935-40. PubMed ID: 11402974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss on the web: A pilot study comparing a structured behavioral intervention to a commercial program.
    Gold BC; Burke S; Pintauro S; Buzzell P; Harvey-Berino J
    Obesity (Silver Spring); 2007 Jan; 15(1):155-64. PubMed ID: 17228043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduced-glycemic load diet in the treatment of adolescent obesity.
    Ebbeling CB; Leidig MM; Sinclair KB; Hangen JP; Ludwig DS
    Arch Pediatr Adolesc Med; 2003 Aug; 157(8):773-9. PubMed ID: 12912783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.
    Rössner S; Sjöström L; Noack R; Meinders AE; Noseda G
    Obes Res; 2000 Jan; 8(1):49-61. PubMed ID: 10678259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results.
    Flechtner-Mors M; Ditschuneit HH; Johnson TD; Suchard MA; Adler G
    Obes Res; 2000 Aug; 8(5):399-402. PubMed ID: 10968732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease.
    Cook SA; MacLaughlin H; Macdougall IC
    Nephrol Dial Transplant; 2008 Jan; 23(1):263-8. PubMed ID: 17977872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.